Anticoagulation strategies for extracorporeal membrane oxygenation: agents, intensity, and monitoring

PURPOSE OF REVIEW: Anticoagulation is among the most challenging aspects of extracorporeal membrane oxygenation (ECMO), during which patients remain at risk of both bleeding and thrombosis. This review synthesizes current evidence across the three interconnected domains of anticoagulation: agent, intensity, and monitoring. RECENT FINDINGS: Unfractionated heparin remains the first-line anticoagulant, although evidence supporting its superiority over alternative agents is limited. Direct thrombin inhibitors and, more recently, therapeutic low-molecular-weight heparin have emerged as alternatives. Anticoagulation intensity has historically lacked standardized definitions, while observational data linking higher activated partial thromboplastin time values to bleeding have contributed to a shift toward lower anticoagulation targets. Available assays provide complementary rather than interchangeable information, and no single test reliably reflects anticoagulant effect or predicts outcomes, although anti-Xa is emerging as the most informative single assay for unfractionated heparin. SUMMARY: Recent evidence supports reduced-intensity anticoagulation during contemporary ECMO, although the lower limit of safe anticoagulation remains undefined and no single agent, target, or assay is optimal for every patient. Anticoagulation should therefore be individualized by integrating agent, intensity, and monitoring according to patient characteristics, circuit performance, and the evolving balance between thrombosis and bleeding.

Authors

Institutions

Publication Details

Journal
Current Opinion in Anaesthesiology
Published
2026-11-20
DOI
https://doi.org/10.1097/aco.0000000000001727
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Anticoagulation strategies for extracorporeal membrane oxygenation: agents, intensity, and monitoring

Nina Buchtele, Marco Giani, Gennaro Martucci, Marta Frazzei
1 links
Current Opinion in Anaesthesiology
Mechanical Circulatory Support Devices
article

Anticoagulation strategies for extracorporeal membrane oxygenation: agents, intensity, and monitoring

Nina Buchtele, Marco Giani, Gennaro Martucci, Marta Frazzei
article en

Abstract

PURPOSE OF REVIEW: Anticoagulation is among the most challenging aspects of extracorporeal membrane oxygenation (ECMO), during which patients remain at risk of both bleeding and thrombosis. This review synthesizes current evidence across the three interconnected domains of anticoagulation: agent, intensity, and monitoring. RECENT FINDINGS: Unfractionated heparin remains the first-line anticoagulant, although evidence supporting its superiority over alternative agents is limited. Direct thrombin inhibitors and, more recently, therapeutic low-molecular-weight heparin have emerged as alternatives. Anticoagulation intensity has historically lacked standardized definitions, while observational data linking higher activated partial thromboplastin time values to bleeding have contributed to a shift toward lower anticoagulation targets. Available assays provide complementary rather than interchangeable information, and no single test reliably reflects anticoagulant effect or predicts outcomes, although anti-Xa is emerging as the most informative single assay for unfractionated heparin. SUMMARY: Recent evidence supports reduced-intensity anticoagulation during contemporary ECMO, although the lower limit of safe anticoagulation remains undefined and no single agent, target, or assay is optimal for every patient. Anticoagulation should therefore be individualized by integrating agent, intensity, and monitoring according to patient characteristics, circuit performance, and the evolving balance between thrombosis and bleeding.

Current Opinion in Anaesthesiology
Azienda Ospedaliera San Gerardo (IT), Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IT), University of Milano-Bicocca (IT), Medical University of Vienna (AT)
Good health and well-being
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon